Delivery Order SPE2DB22D1106-SPE2DB24FEZA0
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $396,555.98 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, which is a subsidiary of Amerisourcebergen Corporation. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, allowing the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.07 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $1,260.58 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract was awarded without a set-aside designation and has an ultimate completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of pharmaceutical products and medical supplies to support the DLA's mission of providing logistics, acquisition, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,864.93, is a delivery order for pharmaceutical and medical products to support the DLA's Pharmaceutical Division. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,327.08 firm fixed-price delivery order is for the medication Corlanor 5 mg tablet, with an ultimate completion date of April 11, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. government awarded a Firm Fixed Price Delivery Order contract worth $1,653.12 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has a completion date of June 4, 2024, is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA that serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract requires Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as...
This is a $36,609.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order, which has an ultimate completion date of April 16, 2024, is for the provision of pharmaceutical and medical supplies to the DLA. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the U.S. Defense Logistics Agency (DLA). The $48,301.28 firm-fixed-price delivery order contract has an ultimate completion date of May 20, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,402.55, with a completion date of May 28, 2024. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...